Skip to main content

Eppendorf s Nascent Microarray Unit Gets New Home; Plans Product Debut in Mid- 03

NEW YORK, Nov. 27 - German lab-equipment giant Eppendorf has found a new home for its young microarray subsidiary, the company said today.

 

Eppendorf Array Technology's new digs are in Namur, a small town about an hour south of Brussels, Belgium. The space employs 25 people, most of whom are researchers, said Jörn Peplow, a spokesman for Eppendorf.


The town surroundings will be familiar to most of EAT's staff: The unit began life as a spin-off of the University of Namur. In July, Eppendorf acquired a majority interest in the young company, which at the time was called
Advanced Array Technology, in order to gain a foothold in the microarray market.


In recent months, EAT researchers have been using the company's labeling technology in more than 20 projects ranging from gene expression, transcription factors, and protein chips, according to Hamburg-based Eppendorf.


The company expects EAT to launch its first product lines of low-density microarray chips, scanners, and reagents in the first half of next year, said Peplow. He said the line will be "continuously expanded."

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.